Antisynthetase syndrome: Analysis of 11 cases

Marguerie, 1990, Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes, Q J Med, 1019, 10.1093/qjmed/77.1.1019 Vargas-Leguás, 2007, [Polymyositis-dermatomyositis: incidence in Spain (1997–2004)] Spanish, Med Clin (Barc), 129, 721, 10.1157/13113285 Labirua-Iturburu, 2011, Síndrome por anticuerpos antisintetasa, Med Clin (Barc), 137, 77, 10.1016/j.medcli.2011.02.026 Ingegnoli, 2012, Interstitial lung disease outcomes by high-resolution computed tomography (HRCT) in Anti-Jo1 antibody-positive polymyositis patients: a single centre study and review of the literature, Autoimmun Rev, 11, 335, 10.1016/j.autrev.2011.09.007 Trallero-Araguás, 2016, Clinical manifestations and long-term outcome of anti-Jo1 antisynthetase patients in a large cohort of Spanish patients from the GEAS-IIM group, Semin Arthritis Rheum, 46, 225, 10.1016/j.semarthrit.2016.03.011 2002, ATS statement: guidelines for the six-minute walk test, Am J Respir Crit Care Med, 166, 111, 10.1164/ajrccm.166.1.at1102 Hamaguchi, 2013, Common and distinct clinical features in adult patients with anti-aminoacyl-tRNA synthetase antibodies: heterogeneity within the syndrome, PLoS One, 8, e60442, 10.1371/journal.pone.0060442 Hervier, 2012, Hierarchical cluster and survival analyses of antisynthetase syndrome: phenotype and outcome are correlated with anti-tRNA synthetase antibody specificity, Autoimmunity Rev, 12, 210, 10.1016/j.autrev.2012.06.006 Váncsa, 2009, Characteristics of interstitial lung disease in SS-A positive/Jo-1 positive inflammatory myopathy patients, Rheumatol Int, 29, 989, 10.1007/s00296-009-0884-9 Chatterjee, 2010, Severe pulmonary hypertension in anti-Jo-1 syndrome, Arthritis Care Res, 62, 425, 10.1002/acr.20109 Marie, 2013, Functional outcome and prognostic factors in anti-Jo1 patients with antisynthetase syndrome, Arthritis Res Ther, 15, R149, 10.1186/ar4332